Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Áron Cseh

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Orvosi Hetilap|March 16, 2025
[The characteristics of pediatric-onset inflammatory bowel disease based on our 20-year-long study]Luca Tóbi, Áron Cseh
Orvosi Hetilap|May 9, 2021
Significance and effects of prenatal and postnatal microbiome in the period of early individual development and options for interventional treatmentVilmos Fülöp, János Demeter, Áron Cseh
Orvosi Hetilap|February 6, 2022
The gastrointestinal effects of COVID–19 infection during childhood and among the children affected with inflammatory bowel diseaseLuca Tóbi, Bence Prehoda, Anna Balogh, et al.
Orvosi Hetilap|January 18, 2021
Foreign body type reaction causing differential diagnostic difficulty after appendectomyTímea Seszták, Attila Kálmán, Áron Cseh, et al.
Orvosi Hetilap|July 2, 2023
[Changes of violent suicide attempts during the first two years of COVID-19 pandemic in Dr. Manninger Jenő National Traumatology Center, Hungary.]Áron Cseh, Bence Prehoda, Luca Tóbi, et al.
Clinical & Developmental Immunology|October 5, 2011
Adaptive immunity in ankylosing spondylitis: phenotype and functional alterations of T-cells before and during infliximab therapyBalázs Szalay, Gergo Mészáros, Áron Cseh, et al.
The Clinical Respiratory Journal|January 15, 2016
Long time enzyme replacement therapy stabilizes obstructive lung disease and alters peripheral immune cell subsets in Fabry patientsBalázs Odler, Áron Cseh, Tamás Constantin, et al.
Therapeutic Advances in Gastroenterology|August 19, 2024
Transition is associated with lower disease activity, fewer relapses, better medication adherence, and lower lost-to-follow-up rate as opposed to self-transfer in pediatric-onset inflammatory bowel disease patients: results of a longitudinal, follow-up, controlled studyLuca Tóbi, Bence Prehoda, Anna M Balogh, et al.
Digestive Diseases and Sciences|August 5, 2010
Immune phenotype of children with newly diagnosed and gluten-free diet-treated celiac diseaseÁron Cseh, Barna Vásárhelyi, Balázs Szalay, et al.
Oxidative Medicine and Cellular Longevity|September 23, 2020
PARK7 Diminishes Oxidative Stress-Induced Mucosal Damage in Celiac DiseaseApor Veres-Székely, Mária Bernáth, Domonkos Pap, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Orvosi Hetilap|March 16, 2025
[The characteristics of pediatric-onset inflammatory bowel disease based on our 20-year-long study]Luca Tóbi, Áron Cseh
Orvosi Hetilap|May 9, 2021
Significance and effects of prenatal and postnatal microbiome in the period of early individual development and options for interventional treatmentVilmos Fülöp, János Demeter, Áron Cseh
Orvosi Hetilap|February 6, 2022
The gastrointestinal effects of COVID–19 infection during childhood and among the children affected with inflammatory bowel diseaseLuca Tóbi, Bence Prehoda, Anna Balogh, et al.
Orvosi Hetilap|January 18, 2021
Foreign body type reaction causing differential diagnostic difficulty after appendectomyTímea Seszták, Attila Kálmán, Áron Cseh, et al.
Orvosi Hetilap|July 2, 2023
[Changes of violent suicide attempts during the first two years of COVID-19 pandemic in Dr. Manninger Jenő National Traumatology Center, Hungary.]Áron Cseh, Bence Prehoda, Luca Tóbi, et al.
Clinical & Developmental Immunology|October 5, 2011
Adaptive immunity in ankylosing spondylitis: phenotype and functional alterations of T-cells before and during infliximab therapyBalázs Szalay, Gergo Mészáros, Áron Cseh, et al.
The Clinical Respiratory Journal|January 15, 2016
Long time enzyme replacement therapy stabilizes obstructive lung disease and alters peripheral immune cell subsets in Fabry patientsBalázs Odler, Áron Cseh, Tamás Constantin, et al.
Therapeutic Advances in Gastroenterology|August 19, 2024
Transition is associated with lower disease activity, fewer relapses, better medication adherence, and lower lost-to-follow-up rate as opposed to self-transfer in pediatric-onset inflammatory bowel disease patients: results of a longitudinal, follow-up, controlled studyLuca Tóbi, Bence Prehoda, Anna M Balogh, et al.
Digestive Diseases and Sciences|August 5, 2010
Immune phenotype of children with newly diagnosed and gluten-free diet-treated celiac diseaseÁron Cseh, Barna Vásárhelyi, Balázs Szalay, et al.
Oxidative Medicine and Cellular Longevity|September 23, 2020
PARK7 Diminishes Oxidative Stress-Induced Mucosal Damage in Celiac DiseaseApor Veres-Székely, Mária Bernáth, Domonkos Pap, et al.
Pageof 3